Investigation of the efficacy of an antiemetic, aprepitant and its drug interaction with prednisolone in CHOP or R-CHOP therapy

Trial Profile

Investigation of the efficacy of an antiemetic, aprepitant and its drug interaction with prednisolone in CHOP or R-CHOP therapy

Completed
Phase of Trial: Phase IV

Latest Information Update: 03 Dec 2013

At a glance

  • Drugs Aprepitant (Primary) ; Prednisolone (Primary) ; Cyclophosphamide; Doxorubicin; Granisetron; Rituximab; Vincristine
  • Indications Chemotherapy-induced nausea and vomiting; Non-Hodgkin's lymphoma
  • Focus Pharmacokinetics
  • Most Recent Events

    • 03 Dec 2013 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan record.
    • 20 Jun 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top